Pharmaceutical company Merck is requesting emergency use authorization for an experimental COVID-19 drug. It targets the CCP (Chinese Communist Party) virus’s ability to make copies of itself.
Merck to Request Approval for COVID-19 Drug
By Fae Courter
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.